PATHELEN®WoundPowder
A new and innovative treatment for open wounds
PATHELEN® WoundPowder is a new microporous silica powder, that adsorbs wound exudate, reducing the healing time of chronic wounds and offers a cost-effective alternative to the current treatment options for wounds.
PATHELEN® is a pioneering European Class I Certified, U.S.FDA approved medical device without side effects and antimicrobial resistant safe.
PATHELEN® WoundPowder is an effective and powerful replacement for all other currently available antimicrobial wound treatment devices.
*PATHELEN® Woundpowder and PATHELEN® Hybrid are the same product. PATHELEN® is sold as PATHELEN® Woundpowder in Ghana & Nigeria only.
3.Guest et al BMJ Open 2018; 8:e021769.
PATHELEN® WoundPowder is a powder which contains both hydrophilic and hydrophobic silicas in a highly porous structure. Through capillary action, these silicas act to irreversibly adsorb wound exudative material (including bacterial toxins) to the upper surface of the layers of the powder from where it effectively evaporates.
PATHELEN® WoundPowder thus “de-toxifies” and cleans the wound.
PATHELEN® WoundPowder is not antibacterial but withdraws water from a bacterial biofilm, disrupting its structure and allowing the host’s immune system to gain entry and destroy the microorganisms present.
Due to its mode of action, PATHELEN® WoundPowder is able to treat a WIDE range of acute and chronic wounds.
Infected burn wounds
Noma
Diabetic/ neuropathic ulcers
Exuding wounds
Wounds with resistant nuclei
Fungating, cancerous or malignant lesions and wounds with necrotic tissue
Post-operative wounds
Traumatic wounds
Elephantiasis open wounds
Any open wounds with a biofilm
INGREDIENTS DESCRIPTION
Aerosil 300 Pharma
- Hydrophilic highly dispersed silica with an ability to absorb pathogenic protein substances (up to 800 mg/g) including microbial enzymes and toxins.
- The high level of hydroxyl (-OH) groups on the silica attract water and produce a dehydrating effect on the wound, removing oedematous fluid
Aerosil R972 Pharma
- Hydrophobic highly dispersed silica which absorbs low and middle molecular metabolites via capillary action
- Combing hydrophilic and hydrophobic silica therefore allows absorption of a much wider range of substances and pathogenic organisms within wounds
Benzalkonium Chloride
- Forms a molecular layer over the surface of the silica and serves as a surfactant and disinfectant
By disrupting the wound’s biofilm, it allows entry of the body’s own immune cells, which destroy microorganisms within the biofilm, promoting the natural healing process and reducing the need for antibiotics.
PATHELEN® WoundPowder is an effective and powerful replacement for all other currently available antimicrobial wound treatment devices.
Clinical practice shows that the current, individual use of other antimicrobial agents in the treatment of purulo-inflammatory diseases and purulent wounds, does not always lead to the desired result. Additionally, misuse of antibiotics has contributed to the emergence of resistant (hospital) strains of pathogenic microorganisms, including methicillin-resistant Staphylococcus aureus (MRSA), and become a serious challenge for modern medicine.
PATHELEN® WoundPowder can solve this problem, utilising new compositions based on highly dispersed silicas and which have enhanced absorptive, anti-inflammatory and wound-healing abilities for the treatment of a wide range of diseases caused by pathogenic microorganisms, in particular, purulent wounds. The intensity of the regeneration process and healing of infected ulcers and wounds depends largely on the speed with which they are cleared of pus and necrotic tissues. Applique sorption, a method of wound healing in which an absorbent in powder form is applied to the wound as a dressing, greatly accelerates this process. This absorption detoxification restores the integrity of the skin and mucous membranes by the removal of microbial cells, bacterial toxins and toxic metabolites of wound fluid and wound cavities in direct contact with the surface of PATHELEN®.
Another important therapeutic factor in the first phase of wound healing is dehydration, i.e. absorption of fluid from the wound cavity and perifocal tissues. Hydrophilic highly dispersed silica (HDS) can be used in the first phase of wound healing. Its detoxifying action is due to the absorption of pathogenic protein substances (up to 800 mg/g), including microbial enzymes, exo-and endotoxins (Lipopolysaccharides) and micro-organisms.
PATHELEN® contains a unique patented formula, which when shaken for 15-20 seconds, will grow visibly in density by more than 20 times, creating the advanced sorption property and filling the bottle content
How do I use PATHELEN®
How fast does it work?
Is there a restriction on how often it can be used?
Does PATHELEN® stick on the wound when the dressing is removed?
Can PATHELEN® be used safely on children/babies and pregnant women?
Can PATHELEN® be administered without specialist training?
Medical Device Class I - EMA European Medicine Agency (CE) Swissmedic registered under CH-201805-0002
U.S. FDA Regulation Number 3017399130
Nigerian NAFDAC 03-6974
Ghana FDA FDA/D.19-3044
Reuters issued a study report on ’Surgery death rates in Africa is twice the global average’ in January 2018.
Reuters issued a study report on ’Surgery death rates in Africa is twice the global average’ in January 2018.
Reuters issued a study report on ’Surgery death rates in Africa is twice the global average’ in January 2018.
Explore other products
PATHELEN® Hybrid



PATHELEN® Hybrid Vet



PATHELEN® Alkaline Vitality Complex



See the amazing results of PATHELEN® treatments in our Case Studies.
PATHELEN® Hybrid



PATHELEN® Hybrid Vet



PATHELEN® Alkaline Vitality Complex


